Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40-billion-pound sales projection ...
GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...
A bold guidance raise, fresh FDA approval, and pipeline deals set the stage for GSK's post-Walmsley transformation.
GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s ...
The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...
Cash generated from operations totaled £2.5 billion, with free cash flow of £1.2 billion. GSK declared a dividend of 16 pence ...
GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by ...
GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer ...
Cash generated from operations totaled £2.5 billion, with free cash flow of £1.2 billion. GSK declared a dividend of 16 pence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback